Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sernova Global Partnership Family Office Presentation

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon May 25, 2021 1:52pm

123 Views

Post# 33260797

RE:RE:Sernova Global Partnership Family Office Presentation

Dr. Toleikis seemed to imply that they were very close to bringing a thyroid treatment to a first in human clinical trial. One slide mentions that they've determined their clinical investigator and the regulatory package is in progress. He also mentioned that Thyroid would be their indication to enter clinical trials next. Hopefully they can finish that regulatory package and get it reviewed and approved relatively quick. From the FDA website, the review team has 30 days to review the original IND (Investigational New Drug) application to determine whether or not the clinical trial is approved.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China